Home/Filings/4/0001437749-22-006742
4//SEC Filing

PEARSON J EDWARD 4

Accession 0001437749-22-006742

CIK 0001095565other

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 4:24 PM ET

Size

18.1 KB

Accession

0001437749-22-006742

Insider Transaction Report

Form 4
Period: 2022-03-17
PEARSON J EDWARD
Senior Vice President
Transactions
  • Exercise/Conversion

    Common Stock Holding

    2022-03-17+14,048191,632 total
  • Exercise/Conversion

    Restricted Share Units

    2022-03-171,8640 total
    Exercise: $0.00Common Stock (1,864 underlying)
  • Tax Payment

    Common Stock Holding

    2022-03-17$19.94/sh3,421$68,215188,211 total
  • Exercise/Conversion

    Restricted Share Units

    2022-03-178,75010,500 total
    Exercise: $0.00Common Stock (8,750 underlying)
  • Exercise/Conversion

    Restricted Share Units

    2022-03-171,4301,667 total
    Exercise: $0.00Common Stock (1,430 underlying)
  • Exercise/Conversion

    Restricted Share Units

    2022-03-171,1463,724 total
    Exercise: $0.00Common Stock (1,146 underlying)
  • Exercise/Conversion

    Restricted Share Units

    2022-03-178584,859 total
    Exercise: $0.00Common Stock (858 underlying)
Footnotes (9)
  • [F1]Shares acquired on vesting of restricted share units.
  • [F2]Shares withheld for payment of tax liability.
  • [F3]Each restricted share unit (RSU) represents the contingent right to receive one share of common stock upon vesting of the unit.
  • [F4]The RSUs are subject to a four year vesting schedule, contingent upon continued service at the time of vesting. 15% vest on March 15, 2019, 20% vest on March 15, 2020, 30% vest on March 15, 2021, and the remaining 35% vest on March 15, 2022.
  • [F5]Not applicable.
  • [F6]Vesting of these RSUs is contingent upon continued service at the time of vesting and the achievement of certain performance criteria. The performance criteria are established on an annual basis by the Compensation Committee of the Board of Directors. Up to 10% vest on March 15, 2019 for the period January 1, 2018 through December 31, 2018; up to 15% vest on March 15, 2020 for the period January 1, 2019 through December 31, 2019; up to 20% vest on March 15, 2021 for the period January 1, 2020 through December 31, 2020; up to 25% vest on March 15, 2022 for the period January 1, 2021 through December 31, 2021; and up to 30% vest on March 15, 2023 for the period January 1, 2022 through December 31, 2022. Vesting is determined based on actual performance. The performance criteria for the period January 1, 2021 through December 31, 2021 was achieved; therefore 25% of the awards vested on March 15, 2022.
  • [F7]The RSUs are subject to a four year vesting schedule, contingent upon continued service at the time of vesting. 15% vest on March 15, 2020, 20% vest on March 15, 2021, 30% vest on March 15, 2022, and the remaining 35% vest on March 15, 2023.
  • [F8]The RSUs are subject to a four year vesting schedule, contingent upon continued service at the time of vesting. 15% vest on March 11, 2021, 20% vest on March 11, 2022, 30% vest on March 11, 2023, and the remaining 35% vest on March 11, 2024.
  • [F9]The RSUs are subject to a four year vesting schedule, contingent upon continued service at the time of vesting. 15% vest on March 17, 2022, 20% vest on March 17, 2023, 30% vest on March 17, 2024, and the remaining 35% vest on March 17, 2025.

Issuer

HEALTHSTREAM INC

CIK 0001095565

Entity typeother

Related Parties

1
  • filerCIK 0001249921

Filing Metadata

Form type
4
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 4:24 PM ET
Size
18.1 KB